Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Go back to Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism| (NASDAQ: RZLT) | Delayed: 5.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.15 | 52 Week High | $ | |||
| Open | $5.15 | 52 Week Low | $ | |||
| Day High | $5.15 | P/E | N/A | |||
| Day Low | $5.15 | EPS | $ | |||
| Volume | 10,865 | |||||
